NYSE:AVTR - Avantor Stock Price, News & Analysis

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor Inc (NYSE:AVTR) released its earnings results on Tuesday, August, 6th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.17 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.52 billion. The company's revenue was up 3.7% on a year-over-year basis. View Avantor's Earnings History.

Avantor is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Avantor.

Avantor issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of $0.55-0.58 for the period, compared to the Thomson Reuters consensus estimate of $0.66. The company issued revenue guidance of $6.08-6.14 billion, compared to the consensus revenue estimate of $6.10 billion.

21 equities research analysts have issued 12 month price targets for Avantor's stock. Their predictions range from $18.70 to $23.00. On average, they expect Avantor's stock price to reach $20.8059 in the next twelve months. This suggests a possible upside of 25.9% from the stock's current price. View Analyst Price Targets for Avantor.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 3 hold ratings and 18 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Avantor.

Media stories about AVTR stock have been trending negative on Sunday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avantor earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Avantor.

Some companies that are related to Avantor include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Eastman Chemical (EMN), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Cisco Systems (CSCO), Johnson & Johnson (JNJ), CSX (CSX) and Mcdonald's (MCD).

(AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor's lock-up period expires on Wednesday, November 13th. Avantor had issued 207,000,000 shares in its public offering on May 17th. The total size of the offering was $2,898,000,000 based on an initial share price of $14.00. After the end of Avantor's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Avantor's stock is owned by a variety of of institutional and retail investors. Top institutional investors include New Mountain Vantage Advisers L.L.C. (19.42%), Vanguard Group Inc. (3.45%), Nuveen Asset Management LLC (2.89%), Viking Global Investors LP (1.99%), Senator Investment Group LP (1.80%) and Artal Group S.A. (1.23%). View Institutional Ownership Trends for Avantor.

AVTR stock was bought by a variety of institutional investors in the last quarter, including New Mountain Vantage Advisers L.L.C., Vanguard Group Inc., Nuveen Asset Management LLC, Viking Global Investors LP, Senator Investment Group LP, Artal Group S.A., Egerton Capital UK LLP and Marshall Wace North America L.P.. View Insider Buying and Selling for Avantor.

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of AVTR stock can currently be purchased for approximately $16.53.

Avantor has a market capitalization of $9.40 billion. Avantor employs 12,000 workers across the globe.View Additional Information About Avantor.

The official website for Avantor is http://www.avantorsciences.com/.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company can be reached via phone at 610-386-1700 or via email at [email protected]